Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series

Abstract Background Cystic fibrosis (CF) is characterized by inflammation, progressive lung disease, and respiratory failure. Although the relationship is not well understood, patients with CF are thought to have a higher prevalence of asthma than the general population. CF Foundation (CFF) annual r...

Full description

Bibliographic Details
Main Authors: Lijia Zhang, Larry Borish, Anna Smith, Lindsay Somerville, Dana Albon
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Cystic fibrosis
Mepolizumab
Asthma
Allergic bronchopulmonary aspergillosis/mycosis
Type 2 inflammation
Online Access:https://doi.org/10.1186/s13223-019-0397-3

Similar Items

Similar Items